Title : MiR-624-5p enhances NLRP3 augmented gemcitabine resistance via EMT/IL-1β/Wnt/β-catenin signaling pathway in ovarian cancer.

Pub. Date : 2022 Mar

PMID : 35124344






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Further, the study also analyzed the regulatory role of NLRP3 in resistance to gemcitabine among ovarian cancer cells and its underlying interaction mechanisms with Wnt/beta-catenin in vitro. gemcitabine NLR family pyrin domain containing 3 Homo sapiens
2 The current in vitro study detailed that when downregulating NLRP3, it could enhance the gemcitabine sensitivity in GRC cells. gemcitabine NLR family pyrin domain containing 3 Homo sapiens
3 In case of gemcitabine-resistant cells, the up-regulation of NLRP3 can increase the drug-resistance through the activation of IL-1beta, EMT and Wnt/beta-catenin signaling pathways. gemcitabine NLR family pyrin domain containing 3 Homo sapiens
4 The current study conducted in vitro experiments and the findings infer that the downregulation of NLRP3 can enhance the sensitivity of gemcitabine among GRC cells. gemcitabine NLR family pyrin domain containing 3 Homo sapiens